Instructions for Golda mv (Gliclazide) 30 mg
English product name
Golda MB
Release Form
tab. with modified release 60 mg: 10, 14, 20, 28, 30, 40, 42, 50, 56, 60, 70, 75, 80, 84, 90, 100, 120, 125, 140, 150, 180, 250 or 300 pcs.
Description Gliclazide
Tablets with modified release of white or white with a yellowish color shade, round, flat cylindrical, with bevel and risk.
1 tab.
glyclase 60 mg
ATC codes
A10BB09 Gliclazide
Active substance
glyclazide
Pharmaco-therapeutic group Gliclazide
Hypoglycemic agent for the oral administration of a group of sulfonyl urea of generation II
Pharmacological effect Gliclazide
Oral hypoglycemic agent, a second generation sulfonyl urea derivative. Stimulates insulin secretion by pancreatic β cells. Increases sensitivity of peripheral tissues to insulin. It appears to stimulate the activity of intracellular enzymes (in particular muscle glycogen synthetase). Reduces the amount of time from the moment of ingestion to the beginning of insulin secretion. Restores early insulin secretion peak, reduces post-prandial hyperglycemia peak.
ATC codes
A10BB09 Gliclazide
Active substance
glyclazide
Testimony
- Type 2 diabetes with insufficient efficiency of diet therapy,
- physical exertion and reduction of body weight.
- Prevention of complications of type 2 diabetes:
- reduction of the risk of microvascular (nephropathy, retinopathy) and macrovascular complications (myocardial infarction,
- stroke).
Pharmaco-therapeutic group Gliclazide
Hypoglycemic agent for the oral administration of a group of sulfonyl urea of generation II
Pharmacological effect Gliclazide
Oral hypoglycemic agent, a second generation sulfonyl urea derivative. Stimulates insulin secretion by pancreatic β cells. Increases sensitivity of peripheral tissues to insulin. It appears to stimulate the activity of intracellular enzymes (in particular muscle glycogen synthetase). Reduces the amount of time from the moment of ingestion to the beginning of insulin secretion. Restores early insulin secretion peak, reduces post-prandial hyperglycemia peak.
- Nosology (ICD codes)
- E11
- Type 2 diabetes
- H36.0
- Diabetic retinopathy
- I52.8
- Other heart attacks for other diseases classified in other rubrics
- I68.8
- Other lesions of brain vessels in diseases classified in other headings
- N08.3
- Glomerular Diabetes Lesions
